.

.

.
![]()
.
eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention..
.ori - ???? .
bother for hernandez stemmed in july 2017, when she suffered a stroke that left her partially blind, which her